11 1. GENERAL ORGANIZATIONAL POLICIES Infusion Team.........................................................................................12 Competence and Competency Validation......................................14 Product Evaluation, Integrity, and Defect Reporting..................17 Informed Consent. ............................................................................... 19 Patient Education.................................................................................22 First Dose Administration..................................................................24 Latex Sensitivity or Allergy...............................................................26 Adverse and Serious Adverse Events..............................................28
Previous Page Next Page